Drug carrier or delivery vehicle for site-specific release

A **drug carrier or delivery vehicle for site-specific release** refers to engineered systems—such as nanoparticles, micelles, liposomes, dendrimers, polymersomes—that are designed to transport therapeutic agents directly to specific biological sites within the body. These carriers enable **targeted drug delivery**, aiming to maximize local concentration at diseased tissue while minimizing exposure elsewhere. This approach can improve efficacy and reduce side effects compared with conventional systemic administration.\n\nDrug carriers are not themselves molecular targets like receptors or enzymes but rather serve as platforms that encapsulate drugs and facilitate their controlled release through various mechanisms—such as pH sensitivity, enzymatic cleavage, temperature changes, light activation—or by exploiting tissue-specific markers for active targeting[1][2][3]. They play an especially important role in delivering drugs with poor solubility/stability or those requiring protection from degradation before reaching their intended site.\n\nBecause "drug carrier/delivery vehicle" is not a single molecule but a broad class of engineered constructs used in pharmaceutical formulations—and does not represent a protein/receptor/enzyme—it should not be considered a canonical therapeutic target. The entry is therefore classified as incorrect under standard molecular target conventions.

Other names

Targeted drug delivery systemSite-specific drug delivery systemDrug carrierDelivery vehicleNanocarrier (context-dependent)